{"filing":{"accession_number":"0001493152-26-044889","cik":"0001419554","ticker":"BBLGW","company_name":"Bone Biologics Corp","form":"8-K","filing_date":"2026-09-29","report_date":"2026-09-28","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226044889/form8-k.htm"},"events":[{"id":35820,"run_id":33014,"accession_number":"0001493152-26-044889","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses Item 5.07 results from Bone Biologics' Annual Meeting of stockholders held on September 28, 2026, including voting outcomes on six proposals: director elections (Stroever, Angle, Gagnon, Meikle), advisory compensation approval, auditor ratification (Weinberg \u0026 Company), warrant issuance authorization under Nasdaq Rule 5635(d), reverse stock split authorization (1-for-2 to 1-for-10), and meeting adjournment. All proposals passed. This is a material shareholder vote disclosure affecting investor understanding of governance and capital structure decisions.","company_name":"Bone Biologics Corp","ticker":"BBLGW","filing_date":"2026-09-29","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":40013,"accession_number":"0001493152-26-044889","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Item 5.07 results from Bone Biologics' Annual Meeting of stockholders held on September 28, 2026, including voting outcomes on six proposals: director elections (Stroever, Angle, Gagnon, Meikle), advisory compensation approval, auditor ratification (Weinberg \u0026 Company), warrant issuance authorization under Nasdaq Rule 5635(d), reverse stock split authorization (1-for-2 to 1-for-10), and meeting adjournment. All proposals passed. This is a material shareholder vote disclosure affecting investor understanding of governance and capital structure decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-29T21:01:42.802894+00:00","company_name":"Bone Biologics Corp","ticker":"BBLGW","filing_date":"2026-09-29"}]}